Cases & Deals

Implanet completes IPO on NYSE Euronext Paris

Clients Implanet SA

Jones Day represented Implanet SA, a medical technology company producing state-of-the-art implants used in orthopaedic surgery, in connection with the issuance of €14.1 million (US$19.4 million) of New Shares in an initial public offering on the NYSE Euronext Paris.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.